![Stephen Joseph Cannon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Stephen Joseph Cannon
Sociétés | Poste | Début | Fin |
---|---|---|---|
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | Fondateur | 01/01/2018 | - |
Historique de carrière de Stephen Joseph Cannon
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Azadyne Ltd.
![]() Azadyne Ltd. Pharmaceuticals: MajorHealth Technology Azadyne Ltd. is an Irish preclinical biotech company that has identified a new target within the body and a previously undrugged pathway to treat autoimmune diseases. Azadyne is based in Dublin2, IE. The company is able to selectively control natural regulatory pathways to modify specific pathogenic immune populations. The company's groundbreaking work in RNA modification has been supported by investment syndicates led by NCL. The company was founded in 2019 by Jason Rutt, Vincent Kelly, Stephen Connon, and Mike Southern to commercialize the pioneering work on the QTRT or TGT pathway carried out in Profs Kelly, Connon & Southerns labs at Trinity College Dublin. | Health Technology |
- Bourse
- Insiders
- Stephen Joseph Cannon
- Expérience